Yantai Lnc Biotechnology Singapore Pte. Ltd.

This early-stage study tested a new radioactive drug called 177Lu-LNC1004 in 11 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug is safe and to find the best dose for future studies. Participants received up to …

This early-phase trial tested a new radioactive tracer called 18F-LNC1007 in 8 people—healthy volunteers and cancer patients with few small tumors. The goal was to see how the tracer moves through the body, how much radiation it gives, and if it is safe. Participants had PET/CT s…

This early-phase trial tested a new imaging agent called 68Ga-LNC1007 in 8 adults—some healthy and some with solid tumors. The goal was to check its safety and how it moves through the body after a single injection. Participants were monitored for about 3 weeks, including scans a…